Osiris evaluates establishment of an international subsidiary
Osiris Therapeutics announced it is evaluating the establishment of an international, ex-U.S. subsidiary in recognition of its expanding research and commercial business operations. The Company is currently evaluating different locations, including UK, Singapore and Switzerland. May 21, 2015